Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Shares Outstanding (Weighted Average): 2023-2024

Historic Shares Outstanding (Weighted Average) for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to $24.3 million.

  • Artiva Biotherapeutics' Shares Outstanding (Weighted Average) rose 0.57% to $24.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.4 million, marking a year-over-year increase of 0.57%. This contributed to the annual value of $24.3 million for FY2024, which is 173.43% up from last year.
  • Per Artiva Biotherapeutics' latest filing, its Shares Outstanding (Weighted Average) stood at $24.3 million for FY2024, which was up 173.43% from $8.9 million recorded in FY2023.
  • Artiva Biotherapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $24.3 million for FY2024, and its period low was $8.9 million during FY2023.
  • Its 2-year average for Shares Outstanding (Weighted Average) is $16.6 million, with a median of $16.6 million in 2023.
  • Data for Artiva Biotherapeutics' Shares Outstanding (Weighted Average) shows a peak YoY soared of 173.43% (in 2024) over the last 5 years.
  • Over the past 2 years, Artiva Biotherapeutics' Shares Outstanding (Weighted Average) (Yearly) stood at $8.9 million in 2023, then soared by 173.43% to $24.3 million in 2024.